Catalyst Event
Biogen Inc (BIIB) · Other
From KEDI U.S. Quality500 + Monthly 1% Premium Index(NTR) (KUSQL500P)
5/24/2026, 12:00:00 AM
U.S. FDA decision (PDUFA date) for LEQEMBI IQLIK (lecanemab) subcutaneous autoinjector for treatment initiation in Alzheimer's disease on 2026-05-24; high importance is estimated as FDA approval for a major drug formulation typically results in ≥10% price impact, scheduled.
Korean Translation
2026-05-24로 예정된 알츠하이머병 츘료제 레쯀비 아이클릭(레카네맙) 피하 자가주사제의 츘료 시작에 대한 미국 FDA 결정(PDUFA)이며, 주요 약물의 제형 승인은 통상 10% 이상의 주가 변동을 야기하므로 높은 중요도로 예정됨.
Related Recent Events
CrowdStrike Holdings Inc (CRWD) · Earnings Release
Next earnings release for Q1 2027 is scheduled for 2026-06-09, with analysts forecasting an EPS of $1.07 estimated.
6/9/2026, 12:00:00 AM
Walmart Inc (WMT) · Earnings Release
Walmart's earnings release for Q1 FY2027 is scheduled. A medium impact is estimated as earnings releases are key volatility drivers for retail stocks, expected.
5/21/2026, 12:00:00 AM
ONEOK Inc (OKE) · Other
ONEOK 2026 Annual Meeting of Shareholders on May 20, 2026, scheduled.
5/20/2026, 12:00:00 AM
Fair Isaac Corporation (FICO) · Other
FICO World 2026 is scheduled to take place from May 19-22, 2026.
5/19/2026, 12:00:00 AM
Alphabet Inc (GOOGL) · Other
Google I/O 2026 developer conference is scheduled for 2026-05-19. Developer conferences usually have a 1-5% price impact. Updates on AI, Gemini, and Android are expected.
5/19/2026, 12:00:00 AM
Exelon Corp (EXC) · Earnings Release
Q1 2026 earnings release expected. Analysts forecast an EPS of approximately $0.86 to $0.89 forecasted. This event is expected to have a medium impact as earnings reports often lead to price movements of 5% or more expected.
5/7/2026, 12:00:00 AM